ArticleScientific reports2025
Development of a nomogram for predicting malignancy in BI-RADS 4 breast lesions using contrast-enhanced ultrasound and shear wave elastography parameters.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Contrast-enhanced ultrasound for differentiating benign from malignant Breast Imaging Reporting and Data System 4a breast lesions: a prospective diagnostic accuracy study.Gland surgery · 2026Article
- Different BI-RADS breast cancer diagnosis using MobileNetV1 and vision transformer based on explainable artificial intelligence (XAI).Scientific reports · 2026Article
- Predicting preoperative axillary lymph node metastasis to guide surgical decisions in invasive breast cancer.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study aimed to develop a Least Absolute Shrinkage and Selection Operator (LASSO) logistic regression (LR) model using quantitative imaging features from Shear Wave Elastography (SWE) and Contrast-Enhanced Ultrasound (CEUS) to assess the malignancy risk of BI-RADS 4 breast lesions (BLs). The features predictive of malignancy in the LASSO analysis were used to construct a nomogram. Female patients (n = 111) with BI-RADS 4 BLs detected via routine ultrasound at Ma'anshan People's Hospital underwent SWE, CEUS, and histopathological examinations were enrolled in this study. The histopathological results served as the gold standard. A time-intensity curve (TIC) was used to analyze the peak intensity (PI), area under the curve (AUC), and other CEUS parameters. The Young's modulus was used for the SWE analysis. Bootstrap sampling was used to validate the nomogram. The performance of the model was evaluated using calibration curves, receiver operator characteristics curve (ROC) analysis, and decision curve analysis (DCA). The histopathological analysis revealed 35 malignant and 76 benign BLs. The multivariate LR analysis identified PI (odds ratio [OR] = 5.788, p < 0.05), AUC (OR = 6.920, p < 0.05), and SWE_Max (OR = 10.802, p < 0.05) as predictive of malignancy. The nomogram based on these features demonstrated an AUC of 0.875 (95% CI 0.805-0.945), sensitivity of 88.6%, specificity of 68.4%, good calibration, and excellent clinical utility. The nomogram could be used to improve the classification of BI-RADS 4 BLs and hence reduce the need for invasive biopsies to confirm malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.